UBS Group Raises Moelis & Company (NYSE:MC) Price Target to $47.00

Moelis & Company (NYSE:MCGet Free Report) had its price target boosted by UBS Group from $45.00 to $47.00 in a report released on Thursday, Benzinga reports. The firm currently has a “sell” rating on the asset manager’s stock. UBS Group’s price objective points to a potential downside of 6.36% from the stock’s current price.

A number of other equities research analysts also recently issued reports on the stock. The Goldman Sachs Group raised shares of Moelis & Company from a “sell” rating to a “neutral” rating and boosted their price objective for the company from $53.00 to $58.00 in a research report on Wednesday, March 13th. Keefe, Bruyette & Woods reissued a “market perform” rating and issued a $54.00 price objective (down from $58.00) on shares of Moelis & Company in a research report on Thursday. JMP Securities restated a “market perform” rating on shares of Moelis & Company in a research note on Tuesday, April 9th. JPMorgan Chase & Co. increased their price objective on shares of Moelis & Company from $46.00 to $57.00 and gave the company a “neutral” rating in a research note on Thursday, February 8th. Finally, StockNews.com raised shares of Moelis & Company from a “sell” rating to a “hold” rating in a report on Thursday, February 8th. Two analysts have rated the stock with a sell rating and five have issued a hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $50.80.

Get Our Latest Analysis on MC

Moelis & Company Trading Down 7.0 %

Moelis & Company stock traded down $3.80 during trading hours on Thursday, hitting $50.19. 588,414 shares of the stock traded hands, compared to its average volume of 628,436. The firm’s 50-day moving average price is $54.31 and its two-hundred day moving average price is $51.51. Moelis & Company has a one year low of $33.87 and a one year high of $58.67. The company has a market cap of $3.57 billion, a PE ratio of -138.42 and a beta of 1.35.

Moelis & Company (NYSE:MCGet Free Report) last announced its quarterly earnings data on Wednesday, April 24th. The asset manager reported $0.22 earnings per share for the quarter, topping analysts’ consensus estimates of $0.11 by $0.11. Moelis & Company had a negative net margin of 2.89% and a negative return on equity of 3.82%. The company had revenue of $217.49 million during the quarter, compared to analyst estimates of $219.30 million. During the same period in the previous year, the business earned $0.05 EPS. The firm’s revenue for the quarter was up 17.4% on a year-over-year basis. On average, sell-side analysts expect that Moelis & Company will post 1.47 earnings per share for the current fiscal year.

Insider Buying and Selling at Moelis & Company

In other Moelis & Company news, CFO Joseph Simon sold 8,573 shares of the company’s stock in a transaction dated Thursday, February 29th. The shares were sold at an average price of $54.13, for a total value of $464,056.49. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Moelis & Company news, CEO Kenneth Moelis sold 128,277 shares of Moelis & Company stock in a transaction on Wednesday, February 21st. The stock was sold at an average price of $52.60, for a total transaction of $6,747,370.20. Following the completion of the transaction, the chief executive officer now directly owns 161,810 shares of the company’s stock, valued at $8,511,206. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Joseph Simon sold 8,573 shares of the business’s stock in a transaction dated Thursday, February 29th. The stock was sold at an average price of $54.13, for a total value of $464,056.49. The disclosure for this sale can be found here. Insiders sold a total of 375,185 shares of company stock worth $20,130,225 over the last 90 days. Insiders own 6.96% of the company’s stock.

Institutional Investors Weigh In On Moelis & Company

Several institutional investors have recently bought and sold shares of MC. O ROURKE & COMPANY Inc lifted its position in shares of Moelis & Company by 4.1% during the 4th quarter. O ROURKE & COMPANY Inc now owns 5,644 shares of the asset manager’s stock worth $317,000 after buying an additional 221 shares during the last quarter. Peak Financial Advisors LLC lifted its holdings in Moelis & Company by 2.9% during the first quarter. Peak Financial Advisors LLC now owns 8,715 shares of the asset manager’s stock worth $495,000 after acquiring an additional 245 shares during the period. Capital Investment Advisory Services LLC lifted its holdings in Moelis & Company by 4.4% during the third quarter. Capital Investment Advisory Services LLC now owns 6,023 shares of the asset manager’s stock worth $272,000 after acquiring an additional 256 shares during the period. Mutual of America Capital Management LLC increased its position in Moelis & Company by 0.4% in the third quarter. Mutual of America Capital Management LLC now owns 76,155 shares of the asset manager’s stock worth $3,437,000 after buying an additional 268 shares during the last quarter. Finally, Assetmark Inc. increased its position in Moelis & Company by 22.5% in the fourth quarter. Assetmark Inc. now owns 1,505 shares of the asset manager’s stock worth $84,000 after buying an additional 276 shares during the last quarter. Institutional investors own 91.53% of the company’s stock.

Moelis & Company Company Profile

(Get Free Report)

Moelis & Company operates as an investment banking advisory firm. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic, capital structure, and private funds advisory.

Featured Stories

Analyst Recommendations for Moelis & Company (NYSE:MC)

Receive News & Ratings for Moelis & Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moelis & Company and related companies with MarketBeat.com's FREE daily email newsletter.